Recent research focusing on Tirzepatide at a dosage of 20mg is shedding new light on its potential applications. Early findings suggest that this higher dosage may amplify the drug's ability to regulate blood glucose, potentially offering more significant outcomes for individuals with insulin resistance. Further study is underway to fully understan